Arvinas and Pfizer to out-license vepdegestrant commercialization rights
Go back to Arvinas and Pfizer to out-license vepdegestrant commercialization rights| (NASDAQ: ARVN) | Delayed: 8.27 -0.27 (3.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.54 | 52 Week High | $ | |||
| Open | $8.54 | 52 Week Low | $ | |||
| Day High | $8.54 | P/E | N/A | |||
| Day Low | $8.13 | EPS | $ | |||
| Volume | 423,183 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 24.17 -0.08 (0.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.25 | 52 Week High | $37.39 | |||
| Open | $24.34 | 52 Week Low | $28.25 | |||
| Day High | $24.41 | P/E | 14.65 | |||
| Day Low | $24.10 | EPS | $1.65 | |||
| Volume | 27,519,596 | |||||

